Novo Nordisk says Health Canada has approved its weight loss drug Wegovy to reduce the risk of heart attacks in some adults. Kyle Benning has the details and more in Health Matters for Nov. 27, 2024.
Health Matters
Health Matters: Wegovy approved to reduce heart attack risk
More Videos
-
Health Matters: Health minister to provide update on B.C. teen with bird flu
-
Health Matters: 1 in 20 Canadians not taking their meds as prescribed due to cost, study finds
-
Health Matters: ‘Suicide pod’ creator rejects claim that 1st user was strangled
-
Health Matters: New Brunswick measles outbreak rises to 44 cases
-
Carrot recall expands to Canada
You are viewing an Accelerated Mobile Webpage.
View Original Article